Gentherm Inc

Gentherm Inc. designs and manufactures thermal management and pneumatic comfort technologies for vehicles and medical settings. Its automotive portfolio includes climate control seats, climate control interiors, lumbar and massage comfort systems, valve systems, and climate/comfort electronics, while its medical business supplies patient temperature management systems used in hospitals and care facilities worldwide.

9,1 %

24,2 %

1,2 %

+2,9 %

1.92

1.30

— Gentherm Inc
%
Automotive climate and comfort solutions70% Seat, interior, lumbar, massage and electronic comfort systems for light vehicles.
Automotive valve systems15% Thermal, pneumatic and fluid-control valves used across vehicle subsystems.
Other automotive products5% Battery thermal management, battery cell connection systems and cable systems.
Medical patient temperature management10% Hospital and clinical warming/cooling systems for hyper-hypothermia, normothermia and related therapies.

Gentherm sells primarily to automotive OEMs and seat manufacturers, with products designed into light vehicles built by...

  • Light-vehicle OEMsprimary

    Buy climate control seats, interiors, electronics and valve systems for vehicle platforms because these features improve comfort and differentiation.

  • Seat manufacturersprimary

    Integrate Gentherm comfort and thermal modules into seat assemblies for OEM programs and platform launches.

  • Medical providers and hospitalssecondary

    Purchase patient temperature management systems for intensive care, surgery and broader warming/cooling therapies.

  • Adjacent-market customersemerging

    Buy thermal and comfort technologies for power-sports, commercial vehicles, agriculture, home and office applications.

Gentherm operates globally and aligns manufacturing and engineering locations with major customer programs, especially...

  • Automotive sales are concentrated in North America, Europe and Asia
  • Medical products are used worldwide, with key presence in the U.S., China, Germany and Brazil
  • Manufacturing and engineering are placed near major OEM customers
  • Europe and Asia capacity realignment is part of the current footprint strategy
  • Trade policy and tariffs matter because production spans multiple countries

Gentherm’s strategy centers on profitable growth, operational excellence and financial performance, supported by its...

01
Profitable growth in core automotive and medical technologiesmedium-term

The company wants to scale proven technologies into higher-value applications while protecting margins.

02
Manufacturing footprint optimizationshort-term

Realigning capacity should reduce structural cost, improve efficiency and better match customer demand.

03
Product innovation and adjacent-market expansionmedium-term

New applications can diversify revenue beyond core automotive programs and reduce dependence on one end market.

Gentherm is exposed to cyclical automotive demand, intense supplier competition and customer concentration, all of...

high

Customer concentration in automotive programs

Revenue depends on a limited set of OEM and seat-manufacturer programs, so lost awards or insourcing can quickly reduce volume.

Scope
Principal customers in North America, Europe and Asia
Materiality
high
high

Competitive pricing pressure

Automotive sourcing decisions are driven by cost, quality and timing, which can compress margins when competitors underbid.

Scope
Automotive climate, comfort and valve systems
Materiality
high
high

Tariffs and trade restrictions

Cross-border manufacturing and sourcing expose the company to duties, customs changes and supply-chain disruption.

Scope
China, Mexico, U.S. import/export flows
Materiality
high
high

Medical goodwill impairment

The medical reporting unit’s fair value only modestly exceeds carrying value, making it sensitive to slower growth or margin shortfalls.

Scope
Medical segment
Materiality
high
medium

AI and technology implementation risk

Early-stage AI use could create legal, operational, IP and reputational issues if deployment is ineffective or non-compliant.

Scope
Product development and internal operations
Materiality
medium
Goodwill impairment
Could materially reduce reported earnings and equity
Restructuring accounting
Affects operating income, cash flow and asset balances
Foreign currency translation and transaction gains/losses
Can cause volatility in other income and net earnings
Income tax estimates
Affects net income and comparability across periods

: 28/04/2026